{"pmid":32403954,"title":"Biologics for patients affected by Hidradenitis suppurativa in the COVID-19 era: data from a referral centre of Southern Italy.","text":["Biologics for patients affected by Hidradenitis suppurativa in the COVID-19 era: data from a referral centre of Southern Italy.","J Dermatolog Treat","Marasca, Claudio","Ruggiero, Angelo","Megna, Matteo","Annunziata, Maria Carmela","Fabbrocini, Gabriella","32403954"],"journal":"J Dermatolog Treat","authors":["Marasca, Claudio","Ruggiero, Angelo","Megna, Matteo","Annunziata, Maria Carmela","Fabbrocini, Gabriella"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32403954","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1080/09546634.2020.1769828","keywords":["covid19","inflammatory skin conditions","biologic drugs","hidradenitis"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666802845510270977,"score":9.490897,"similar":[{"pmid":32389715,"title":"Exploring the risk of severe COVID-19 infection in hidradenitis suppurativa patients.","text":["Exploring the risk of severe COVID-19 infection in hidradenitis suppurativa patients.","J Am Acad Dermatol","Seltzer, Janyla A","Okeke, Chidubem A V","Perry, Jessica D","Shipman, William D","Okoye, Ginette A","Byrd, Angel S","32389715"],"journal":"J Am Acad Dermatol","authors":["Seltzer, Janyla A","Okeke, Chidubem A V","Perry, Jessica D","Shipman, William D","Okoye, Ginette A","Byrd, Angel S"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389715","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jaad.2020.05.012","keywords":["covid-19","sars-cov-2","comorbidities","coronavirus","hidradenitis suppurativa","risk factors"],"topics":["Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1666528580103831552,"score":71.77028},{"pmid":32492559,"title":"May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?","text":["May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?","The emergence of the novel betaCoronavirus has raised serious concerns due to the virus rapid dissemination worldwide. Many areas throughout the world are now experiencing the COVID 19 outbreaks with government and policy authorities taking many aggressive isolation or restriction measures, drastically reducing also patient's visits and limiting only to the most urgent ones such as oncological visits or emergencies. Several studies have demonstrated a relationship between increased weight, obesity, diabetes, hypertension and inflammatory skin diseases. Furthermore, weight loss interventions have been shown to improve psoriasis, as well as hidradenitis suppurativa, and increase responsiveness to treatment of this conditions. We suppose that due to aggressive isolation or restriction measures, in the next future dermatologist will face with a common worsening of chronic skin inflammatory conditions due to reduced physical activities, increased intake of calories with the derived increase body weight and always more frequent treatment discontinuation. It is time to start potential preventive strategies which could limit the expected negative impact of COVID-19 related quarantine on skin diseases.","Med Hypotheses","Marasca, Claudio","Ruggiero, Angelo","Napolitano, Maddalena","Fabbrocini, Gabriella","Megna, Matteo","32492559"],"abstract":["The emergence of the novel betaCoronavirus has raised serious concerns due to the virus rapid dissemination worldwide. Many areas throughout the world are now experiencing the COVID 19 outbreaks with government and policy authorities taking many aggressive isolation or restriction measures, drastically reducing also patient's visits and limiting only to the most urgent ones such as oncological visits or emergencies. Several studies have demonstrated a relationship between increased weight, obesity, diabetes, hypertension and inflammatory skin diseases. Furthermore, weight loss interventions have been shown to improve psoriasis, as well as hidradenitis suppurativa, and increase responsiveness to treatment of this conditions. We suppose that due to aggressive isolation or restriction measures, in the next future dermatologist will face with a common worsening of chronic skin inflammatory conditions due to reduced physical activities, increased intake of calories with the derived increase body weight and always more frequent treatment discontinuation. It is time to start potential preventive strategies which could limit the expected negative impact of COVID-19 related quarantine on skin diseases."],"journal":"Med Hypotheses","authors":["Marasca, Claudio","Ruggiero, Angelo","Napolitano, Maddalena","Fabbrocini, Gabriella","Megna, Matteo"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492559","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.mehy.2020.109853","keywords":["covid19","inflammatory skin conditions","obesity","overweight"],"topics":["Prevention"],"weight":1,"_version_":1668623433662988289,"score":66.78546},{"pmid":32283230,"pmcid":"PMC7151529","title":"Adalimumab for Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic: Safety Considerations.","text":["Adalimumab for Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic: Safety Considerations.","J Am Acad Dermatol","Blaszczak, Alecia","Trinidad, John C L","Cartron, Alexander M","32283230"],"journal":"J Am Acad Dermatol","authors":["Blaszczak, Alecia","Trinidad, John C L","Cartron, Alexander M"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283230","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jaad.2020.04.030","keywords":["covid-19","adalimumab","biologics","coronavirus","hidradenitis suppurativa","immunosuppression"],"e_drugs":["Adalimumab"],"topics":["Treatment"],"weight":1,"_version_":1666138491490140161,"score":61.52238},{"pmid":32447800,"title":"Moderate to severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreak.","text":["Moderate to severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreak.","Dermatol Ther","Giulia, Rozzo","Alice, Ramondetta","Teresa, Fierro Maria","Paolo, Dapavo","Simone, Ribero","32447800"],"journal":"Dermatol Ther","authors":["Giulia, Rozzo","Alice, Ramondetta","Teresa, Fierro Maria","Paolo, Dapavo","Simone, Ribero"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32447800","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/dth.13680","keywords":["adalimumab","covid-19","pandemic","apremilast","hidradenitis suppurativa","secukinumab"],"topics":["Treatment"],"weight":1,"_version_":1667698385900011520,"score":61.52238},{"pmid":32360857,"title":"Hidradenitis suppurativa: the importance of virtual outpatient care during COVID-19 pandemic.","text":["Hidradenitis suppurativa: the importance of virtual outpatient care during COVID-19 pandemic.","J Am Acad Dermatol","Shah, Monica","Naik, Haley B","Alhusayen, Raed","32360857"],"journal":"J Am Acad Dermatol","authors":["Shah, Monica","Naik, Haley B","Alhusayen, Raed"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360857","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jaad.2020.04.142","keywords":["covid-19","coronavirus","emergency department","hidradenitis suppurativa","operational strategies","outpatient care","telemedicine"],"topics":["Prevention"],"weight":1,"_version_":1666138495570149377,"score":55.95625}]}